@article{4144087433d24e7791fc074fdb735b6a,
title = "Pediatric Endoscopy Quality Improvement Network Pediatric Endoscopy Reporting Elements: A Joint NASPGHAN/ESPGHAN Guideline",
abstract = "Introduction:High-quality procedure reports are a cornerstone of high-quality pediatric endoscopy as they ensure the clear communication of procedural events and outcomes, guide patient care and facilitate continuous quality improvement. The aim of this document is to outline standardized reporting elements that achieved international consensus as requirements for high-quality pediatric endoscopy procedure reports.Methods:With support from the North American and European Societies of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN and ESPGHAN), an international working group of the Pediatric Endoscopy Quality Improvement Network (PEnQuIN) used Delphi methodology to identify key elements that should be found in all pediatric endoscopy reports. Item reduction was attained through iterative rounds of anonymized online voting using a 6-point scale. Responses were analyzed after each round and items were excluded from subsequent rounds if ≤50% of panelists rated them as 5 ({"}agree moderately{"}) or 6 ({"}agree strongly{"}). Reporting elements that ≥70% of panelists rated as {"}agree moderately{"} or {"}agree strongly{"} were considered to have achieved consensus.Results:Twenty-six PEnQuIN group members from 25 centers internationally rated 63 potential reporting elements that were generated from a systematic literature review and the Delphi panelists. The response rates were 100% for all three survey rounds. Thirty reporting elements reached consensus as essential for inclusion within a pediatric endoscopy report.Discussion:It is recommended that the PEnQuIN Reporting Elements for pediatric endoscopy be universally employed across all endoscopists, procedures and facilities as a foundational means of ensuring high-quality endoscopy services, while facilitating quality improvement activities in pediatric endoscopy.",
keywords = "Computerized/∗organization & administration, Digestive system/∗statistics & numerical data, Documentation/standards, Electronic health records/∗standards, Endoscopy, Medical record systems, Registries",
author = "Walsh, {Catharine M.} and Lightdale, {Jenifer R.} and Fishman, {Douglas S.} and Furlano, {Raoul I.} and Petar Mamula and Gillett, {Peter M.} and Priya Narula and Iva Hojsak and Salvatore Oliva and Matja{\v z} Homan and Riley, {Matthew R.} and Huynh, {Hien Q.} and Rosh, {Joel R.} and Kevan Jacobson and Marta Tavares and Leibowitz, {Ian H.} and Utterson, {Elizabeth C.} and Croft, {Nicholas M.} and Mack, {David R.} and Herbert Brill and Liu, {Quin Y.} and Patrick Bontems and Lerner, {Diana G.} and Jorge Amil-Dias and Kramer, {Robert E.} and Otley, {Anthony R.} and Lusine Ambartsumyan and Veronik Connan and McCreath, {Graham A.} and Thomson, {Mike A.}",
note = "Funding Information: Conflicts of interest: P.B. has served on the advisory boards of Biocodex, Nutricia, and Avanos. P.B. has received honoraria for speaking engagements from AbbVie, Nutricia, and Avanos. N.M.C.'s institution received speaker fees, advisory board fees, and research funding on his behalf from AbbVie, Eli Lilly, Takeda, Shire, Pfizer, and 4D Pharma. D.S.F. has received royalties from UpToDate (“Pediatric Caustic Ingestions”). I.H. has received honoraria for speaking engagements from BioGaia, Oktal Pharma, Nutricia, Abela Pharm, and Nestle. H.Q.H. has received research support from Janssen, AbbVie, Takeda, and Allergan. H.Q.H. has served on the advisory boards of AbbVie and Jansen. K.J. has received research support from Janssen, AbbVie, and the Center for Drug Research and Development (CDRD). K.J. has served on the advisory boards of Janssen, AbbVie, and Merck and participates in the speaker's bureau for AbbVie and Janssen. D.G.L. has received consultant fees from EvoEndo. J.R.L. has received research support from AbbVie and an honorarium from Mead Johnson. A.R.O. has received research support from Janssen, AbbVie, Pfizer, and Eli Lilly. A.R.O. has served on the advisory boards of Janssen, AbbVie, and Eli Lilly and participates in the speaker's bureau for AbbVie and Janssen. J.R.R. has received research support from AbbVie and Janssen. J.R.R. has served on the advisory boards of Janssen, BMS, Eli Lilly, and Pfizer. C.M.W. has received research support from AbbVie. Funding Information: Funding/Support: C.M.W. holds a Career Development Award from the Canadian Child Health Clinician Scientist Program and an Early Researcher Award from the Ontario Ministry of Research and Innovation. D.R.M. is funded in part by a University of Ottawa, Faculty of Medicine Distinguished Clinical Research Chair award. The funders had no role in the design and conduct of the study, decision to publish and preparation, review or approval of the manuscript. Funding Information: Funding for the consensus meeting was provided by NASPGHAN and ESPGHAN, and NASPGHAN administered all aspects of the in-person meeting. The views of the funding bodies did not influence the content of the guideline. Publisher Copyright: {\textcopyright} 2022 Lippincott Williams and Wilkins. All rights reserved.",
year = "2022",
month = mar,
day = "1",
doi = "10.1097/MPG.0000000000003266",
language = "English",
volume = "74",
pages = "S53--S62",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins Ltd.",
}